% Expired Patents = 25.0

EPO Patents = 1

Forward Citations = 1

Loading Chart...

9 inventors (with patents filed for the assignee):

Byung Soo Youn (4 out of 6 patents)

Ho Sup Yoon (4 out of 6 patents)

Han Soo Kim (4 out of 41 patents)

4. Ik Hwan Kim (2 out of 3 patents)

5. Moon Kee Maeng (1 out of 1 patent)

6. Min Ju Ham (1 out of 1 patent)

7. Baik Lin Seong (1 out of 10 patents)

8. Hyeong Deok Choi (1 out of 1 patent)

9. Jun Hwan Kim (1 out of 1 patent)

10. Jun Hwan Kim (0 patent)

4 patents: Sort by Forward Citations

1. 11298353 - Anti-inflammatory composition (2022-04-12),

2. 10744114 - Use of eupatilin as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity (2020-08-18),

3. 10744113 - Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity (2020-08-18),

4. 10370364 - Substituted chromenes for treatment of fibrosis or non-alcoholic steatohepatitis (2019-08-06),

Osteoneurogen Inc. is a biotechnology company focused on developing novel therapies for neurological and orthopedic disorders. Our innovative treatments leverage cutting-edge technology to enhance bone and nerve regeneration, improving patient outcomes and quality of life. With a strong commitment to research and development, we are dedicated to advancing the field of regenerative medicine and transforming the lives of individuals suffering from debilitating conditions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#761 in Seoul

#2,187 in South Korea

Seoul, South Korea

Osteoneurogen Inc.